PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE

被引:1072
|
作者
CHENG, JH
ZHOU, T
LIU, CD
SHAPIRO, JP
BRAUER, MJ
KIEFER, MC
BARR, PJ
MOUNTZ, JD
机构
[1] UNIV ALABAMA,BIRMINGHAM,AL 35294
[2] VET ADM MED CTR,BIRMINGHAM,AL 35294
[3] LXR BIOTECHNOL INC,RICHMOND,CA 94804
关键词
D O I
10.1126/science.7510905
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fas is an apoptosis-signaling receptor molecule on the surface of a number of cell types. Molecular cloning and nucleotide sequence analysis revealed a human Fas messenger RNA variant capable of encoding a soluble Fas molecule lacking the transmembrane domain because of the deletion of an exon encoding this region. The expression of soluble Fas was confirmed by flow cytometry and immunocytochemical analysis. Supernatants from cells transfected with the variant messenger RNA blocked apoptosis induced by the antibody to Fas. Levels of soluble Fas were elevated in patients with systemic lupus erythematosus, and mice injected with soluble Fas displayed autoimmune features.
引用
收藏
页码:1759 / 1762
页数:4
相关论文
共 50 条
  • [21] Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
    Ungefroren, H
    Voss, M
    Jansen, M
    Roeder, C
    Henne-Bruns, D
    Kremer, B
    Kalthoff, H
    CANCER RESEARCH, 1998, 58 (08) : 1741 - 1749
  • [22] The role of Fas-mediated apoptosis in thyroid disease
    Andrikoula, M
    Tsatsoulis, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (06) : 561 - 568
  • [23] JNK activation is not required for Fas-mediated apoptosis
    Low, W
    Smith, A
    Ashworth, A
    Collins, M
    ONCOGENE, 1999, 18 (25) : 3737 - 3741
  • [24] Thyroid carcinoma cells and Fas-mediated apoptosis
    Mitsiades, CS
    Mitsiades, N
    THYROID, 2005, 15 (02) : 178 - 179
  • [25] JNK activation is not required for Fas-mediated apoptosis
    Walter Low
    Anna Smith
    Alan Ashworth
    Mary Collins
    Oncogene, 1999, 18 : 3737 - 3741
  • [26] Receptor-specific regulation of B-cell susceptibility to Fas-mediated apoptosis and a novel Fas apoptosis inhibitory molecule
    Rothstein, TL
    Zhong, XM
    Schram, BR
    Negm, RS
    Donohoe, TJ
    Cabral, DS
    Foote, LC
    Schneider, TJ
    IMMUNOLOGICAL REVIEWS, 2000, 176 : 116 - 133
  • [27] Fas-mediated apoptosis in mouse osteoclasts.
    Wu, X
    McKenna, M
    Feng, X
    McDonald, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S271 - S271
  • [28] Fas-mediated apoptosis in cultured human eosinophils
    Druilhe, A
    Cai, ZZ
    Haile, S
    Chouaib, S
    Pretolani, M
    BLOOD, 1996, 87 (07) : 2822 - 2830
  • [29] Somatic mutation in the absence of fas-mediated apoptosis
    Panoutsakopoulou, V
    Schwaber, J
    FASEB JOURNAL, 1996, 10 (06): : 976 - 976
  • [30] Fas-mediated apoptosis in accelerated graft arteriosclerosis
    Moldovan N.I.
    Qian Z.
    Chen Y.
    Dong C.
    Ying A.
    Hruban R.H.
    Flavahan N.A.
    Baldwin III W.M.
    Sanfilippo F.
    Goldschmidt-Clermont P.J.
    Angiogenesis, 1998, 2 (3) : 245 - 254